Intravascular ultrasound predictors for edge restenosis after newer generation drug-eluting stent implantation.

[1]  Seung‐Jung Park,et al.  Intravascular ultrasound assessment of optimal stent area to prevent in‐stent restenosis after zotarolimus‐, everolimus‐, and sirolimus‐eluting stent implantation , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  G. Nakazawa,et al.  Intravascular ultrasound criteria for determination of optimal longitudinal positioning of sirolimus-eluting stents. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[3]  Seung‐Jung Park,et al.  The relationship and threshold of stent length with regard to risk of stent thrombosis after drug-eluting stent implantation. , 2010, JACC. Cardiovascular interventions.

[4]  P. Fitzgerald,et al.  A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial. , 2010, Journal of the American College of Cardiology.

[5]  Akiko Maehara,et al.  Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. , 2009, JACC. Cardiovascular interventions.

[6]  G. Stone,et al.  A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis. , 2009, JACC. Cardiovascular interventions.

[7]  G. Stone,et al.  An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents. , 2009, The American journal of cardiology.

[8]  P. Fitzgerald,et al.  Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. , 2008, JAMA.

[9]  N. Weissman,et al.  Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment. , 2007, The American journal of cardiology.

[10]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[11]  Young-Hak Kim,et al.  Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. , 2006, European heart journal.

[12]  P. Fitzgerald,et al.  Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). , 2005, The American journal of cardiology.

[13]  G. Stone,et al.  Clinical researchInterventional cardiologyStent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: An intravascular ultrasound study , 2005 .

[14]  P. Fitzgerald,et al.  Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. , 2004, Journal of the American College of Cardiology.

[15]  D. Kang,et al.  Long-term outcomes of minor dissection at the edge of stents detected with intravascular ultrasound. , 2000, The American journal of cardiology.

[16]  G. Stone,et al.  Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. , 1999, Circulation.

[17]  J. A. Painter,et al.  Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. , 1995, Journal of the American College of Cardiology.

[18]  T. Ryan Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). , 1988, Journal of the American College of Cardiology.